Open Market Insiders Trades
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- P - Open market or private purchase of non-derivative or derivative security
- S - Open market or private sale of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
---|---|---|---|---|---|---|
ORCL
|
Bruce R Chizen
Director |
SELL
Open market or private sale
|
Direct | 206,250 Reduced 91.57% |
$10,260,938
$49.75 p/Share
|
Jul 05
2017 |
ALRN
|
Novartis Bioventures LTD
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 266,667 Added 9.49% |
$4,000,005
$15.0 p/Share
|
Jul 05
2017 |
UVSP
|
Charles H Zimmerman
Director |
BUY
Open market or private purchase
|
Direct | 16 Added 0.31% |
$477
$29.81 p/Share
|
Jul 05
2017 |
SCHW
|
Terri R Kallsen
EVP - Investor Services |
SELL
Open market or private sale
|
Indirect | 10,536 Reduced 100.0% |
$454,628
$43.15 p/Share
|
Jul 03
2017 |
SYNH
|
Christopher L Gaenzle
CAO, GC & Sec |
SELL
Open market or private sale
|
Direct | 956 Reduced 2.01% |
$55,974
$58.55 p/Share
|
Jul 03
2017 |
SYNH
|
Alistair Macdonald
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 1,088 Reduced 1.46% |
$63,702
$58.55 p/Share
|
Jul 03
2017 |
NEM
|
Gary J Goldberg
Chief Executive Officer |
SELL
Open market or private sale
|
Indirect | 1,000 Reduced 0.67% |
$31,800
$31.8 p/Share
|
Jul 03
2017 |
NEM
|
Thomas Ronald Palmer
President & CEO |
SELL
Open market or private sale
|
Direct | 1,250 Reduced 1.34% |
$39,750
$31.8 p/Share
|
Jul 03
2017 |
SNX
|
Simon Leung
Chief Business Officer |
SELL
Open market or private sale
|
Direct | 86 Reduced 0.34% |
$10,294
$119.7 p/Share
|
Jul 03
2017 |
SNX
|
Simon Leung
Chief Business Officer |
SELL
Open market or private sale
|
Direct | 914 Reduced 3.5% |
$109,753
$120.08 p/Share
|
Jul 03
2017 |
COST
|
John W Meisenbach
Director |
SELL
Open market or private sale
|
Direct | 1,000 Reduced 14.34% |
$160,280
$160.28 p/Share
|
Jul 03
2017 |
ORCL
|
Mark V Hurd
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 350,000 Reduced 63.19% |
$17,415,999
$49.76 p/Share
|
Jul 03
2017 |
INTC
|
Brian M Krzanich
CEO |
SELL
Open market or private sale
|
Direct | 72,173 Reduced 12.69% |
$2,431,508
$33.69 p/Share
|
Jul 03
2017 |
SNX
|
Dennis Polk
Hyve Solutions Executive |
SELL
Open market or private sale
|
Direct | 1,500 Reduced 4.77% |
$180,180
$120.12 p/Share
|
Jul 03
2017 |
SNX
|
Dennis Polk
Hyve Solutions Executive |
SELL
Open market or private sale
|
Direct | 214 Reduced 0.68% |
$25,616
$119.7 p/Share
|
Jul 03
2017 |
SNX
|
Dennis Polk
Hyve Solutions Executive |
SELL
Open market or private sale
|
Direct | 2,286 Reduced 6.73% |
$274,503
$120.08 p/Share
|
Jul 03
2017 |
EA
|
Andrew Wilson
Chairman & CEO |
SELL
Open market or private sale
|
Indirect | 9,059 Reduced 5.02% |
$961,794
$106.17 p/Share
|
Jul 03
2017 |
EA
|
Patrick Soderlund
Chief Design Officer |
SELL
Open market or private sale
|
Direct | 8,000 Reduced 7.28% |
$848,880
$106.11 p/Share
|
Jul 03
2017 |
EA
|
Laura Miele
President of EA Entertainment |
SELL
Open market or private sale
|
Direct | 750 Reduced 8.33% |
$79,508
$106.01 p/Share
|
Jul 03
2017 |
EA
|
Joel Linzner
EVP Worldwide Business Affairs |
SELL
Open market or private sale
|
Direct | 4,000 Reduced 15.33% |
$424,760
$106.19 p/Share
|
Jul 03
2017 |
EA
|
Chris Bruzzo
Chief Experience Officer |
SELL
Open market or private sale
|
Direct | 1,500 Reduced 4.34% |
$159,315
$106.21 p/Share
|
Jul 03
2017 |
TSLA
|
Kimbal Musk
Director |
SELL
Open market or private sale
|
Direct | 4,690 Reduced 2.82% |
$1,723,716
$367.53 p/Share
|
Jul 03
2017 |
IDCC
|
Scott A Mc Quilkin
Sr. EVP, Innovation |
SELL
Open market or private sale
|
Direct | 500 Reduced 0.62% |
$39,575
$79.15 p/Share
|
Jun 30
2017 |
SYNH
|
Christopher L Gaenzle
CAO, GC & Sec |
SELL
Open market or private sale
|
Direct | 5,917 Reduced 11.29% |
$344,843
$58.28 p/Share
|
Jun 30
2017 |
SYNH
|
Alistair Macdonald
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 9,467 Reduced 11.28% |
$552,494
$58.36 p/Share
|
Jun 30
2017 |
NKE
|
Andrew Campion
CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct | 96,243 Reduced 80.04% |
$5,485,851
$57.0 p/Share
|
Jun 30
2017 |
NKE
|
Eric D Sprunk
CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct | 50,000 Reduced 16.66% |
$2,950,000
$59.0 p/Share
|
Jun 30
2017 |
CB
|
Paul J Krump
Vice Chairman, Chubb Group* |
BUY
Open market or private purchase
|
Indirect | 100 Added 50.0% |
$14,519
$145.19 p/Share
|
Jun 30
2017 |
FDX
|
Kim Jabal
Director |
SELL
Open market or private sale
|
Direct | 609 Reduced 22.48% |
$131,623
$216.13 p/Share
|
Jun 29
2017 |
CRSP
|
Kurt Von Emster
Director |
SELL
Open market or private sale
|
Indirect | 11,610 Reduced 0.47% |
$191,797
$16.52 p/Share
|
Jun 29
2017 |
AMP
|
Randy Kupper
EVP Technology and CIO |
SELL
Open market or private sale
|
Direct | 2,987 Reduced 12.1% |
$389,027
$130.24 p/Share
|
Jun 29
2017 |
SCHW
|
Bernard J. Clark
MD Head of Advisor Services |
SELL
Open market or private sale
|
Indirect | 400 Reduced 0.75% |
$17,600
$44.0 p/Share
|
Jun 29
2017 |
SCHW
|
Marie A Chandoha
CEO - CSIM |
SELL
Open market or private sale
|
Indirect | 100 Reduced 0.71% |
$4,400
$44.0 p/Share
|
Jun 29
2017 |
NVDA
|
Harvey C Jones
Director |
SELL
Open market or private sale
|
Indirect | 50,000 Reduced 7.39% |
$7,542,000
$150.84 p/Share
|
Jun 28
2017 |
ORCL
|
Dorian Daley
EVP and General Counsel |
SELL
Open market or private sale
|
Direct | 200,000 Reduced 86.59% |
$10,188,000
$50.94 p/Share
|
Jun 28
2017 |
INTU
|
Henry Tayloe Stansbury
EVP, Chief Technology Officer |
SELL
Open market or private sale
|
Direct | 1,871 Reduced 67.72% |
$253,128
$135.29 p/Share
|
Jun 28
2017 |
EVBG
|
Claudia Dent
SVP, Product Management |
SELL
Open market or private sale
|
Direct | 4,000 Reduced 100.0% |
$103,800
$25.95 p/Share
|
Jun 28
2017 |
CRSP
|
Kurt Von Emster
Director |
SELL
Open market or private sale
|
Indirect | 31,592 Reduced 1.27% |
$538,328
$17.04 p/Share
|
Jun 28
2017 |
PLXS
|
Oliver K. Mihm
Exec VP & COO |
SELL
Open market or private sale
|
Direct | 400 Reduced 7.51% |
$21,520
$53.8 p/Share
|
Jun 28
2017 |
ADBE
|
Daniel Rosensweig
Director |
SELL
Open market or private sale
|
Direct | 7,000 Reduced 44.3% |
$1,007,650
$143.95 p/Share
|
Jun 28
2017 |
ADBE
|
Daniel Rosensweig
Director |
SELL
Open market or private sale
|
Indirect | 4,000 Reduced 63.82% |
$573,120
$143.28 p/Share
|
Jun 28
2017 |
CRSP
|
Kurt Von Emster
Director |
SELL
Open market or private sale
|
Indirect | 33,434 Reduced 1.33% |
$582,755
$17.43 p/Share
|
Jun 27
2017 |
QCOM
|
Alexander H Rogers
President QTL & Global Affairs |
SELL
Open market or private sale
|
Direct | 438 Reduced 14.37% |
$24,655
$56.29 p/Share
|
Jun 27
2017 |
ATNF
|
Polar Asset Management Partners Inc.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 12,500 Reduced 0.83% |
$121,250
$9.7 p/Share
|
Jun 27
2017 |
SNX
|
Andrea M Zulberti
Director |
SELL
Open market or private sale
|
Direct | 2,500 Reduced 16.75% |
$315,000
$126.0 p/Share
|
Jun 27
2017 |
AMT
|
Steven C. Marshall
Former Officer |
SELL
Open market or private sale
|
Direct | 20,548 Reduced 17.12% |
$2,772,336
$134.92 p/Share
|
Jun 27
2017 |
ORCL
|
W Corey West
Controller, EVP, CAO |
SELL
Open market or private sale
|
Direct | 150,000 Reduced 84.28% |
$7,708,500
$51.39 p/Share
|
Jun 26
2017 |
CRSP
|
Kurt Von Emster
Director |
SELL
Open market or private sale
|
Indirect | 48,001 Reduced 1.87% |
$807,857
$16.83 p/Share
|
Jun 26
2017 |
CVS
|
Helena Foulkes
EVP & President-CVS Pharmacy |
SELL
Open market or private sale
|
Direct | 20,333 Reduced 31.12% |
$1,626,640
$80.0 p/Share
|
Jun 26
2017 |
SQ
|
Sarah Friar
Chief Financial Officer |
SELL
Open market or private sale
|
Indirect | 19,200 Reduced 100.0% |
$465,024
$24.22 p/Share
|
Jun 23
2017 |